Allstate Corporation’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,532
Closed -$311K 604
2024
Q4
$311K Buy
+5,532
New +$344K 0.01% 578
2023
Q1
Sell
-10,257
Closed -$508K 335
2022
Q4
$508K Buy
10,257
+162
+2% +$6.62K 0.02% 491
2022
Q3
$328K Sell
10,095
-7,262
-42% -$299K 0.01% 552
2022
Q2
$684K Buy
+17,357
New +$928K 0.02% 429
2022
Q1
Sell
-3,111
Closed -$242K 643
2021
Q4
$242K Sell
3,111
-811
-21% -$71.6K ﹤0.01% 735
2021
Q3
$374K Buy
3,922
+642
+20% +$67.8K 0.02% 572
2021
Q2
$408K Sell
3,280
-1,228
-27% -$147K 0.01% 578
2021
Q1
$594K Buy
4,508
+502
+13% +$68.7K 0.02% 489
2020
Q4
$531K Buy
4,006
+1,470
+58% +$178K 0.02% 493
2020
Q3
$259K Sell
2,536
-2,998
-54% -$259K 0.01% 603
2020
Q2
$481K Buy
+5,534
New +$442K 0.02% 448
2020
Q1
Sell
-10,302
Closed -$953K 635
2019
Q4
$953K Sell
10,302
-573
-5% -$50.4K 0.02% 433
2019
Q3
$983K Buy
10,875
+1,917
+21% +$218K 0.02% 389
2019
Q2
$1.06M Buy
8,958
+1,878
+27% +$189K 0.02% 382
2019
Q1
$613K Buy
7,080
+97
+1% +$8.26K 0.02% 328
2018
Q4
$441K Buy
+6,983
New +$479K 0.01% 333

Other funds holding EXAS

Allstate Corporation's EXAS Position: Q1 2025 in Review

Allstate Corporation sold out of Exact Sciences (EXAS) in Q1 2025, closing a stake of 5,532 shares — an estimated $311K sold.

Allstate Corporation first reported a position in EXAS in Q4 2018 and held it in 16 quarters. The position peaked at $1.06M in Q2 2019. 557 funds tracked by Wall St. Rank hold EXAS as of Q1 2025.

  • Allstate Corporation reported no remaining Exact Sciences position as of Q1 2025 after selling out during the quarter.
  • Allstate Corporation sold 5,532 Exact Sciences shares in Q1 2025, an estimated $311K.
  • Allstate Corporation first reported a position in Exact Sciences in Q4 2018 and held it in 16 quarters.
  • Allstate Corporation's Exact Sciences position peaked at $1.06M in Q2 2019.
  • 557 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2025.

Based on Allstate Corporation's 13F filing for Q1 2025, filed 14 May 2025.